User contributions for 192.241.82.205

26 August 2026

• 17:1117:11, 26 August 2026 diff hist +4,336 N GLP-1 Receptor Agonists (GLP1RA) - New Zealand Society For The Study Of Diabetes Created page with "<br>There is no conclusive data to suggest that either dulaglutide or liraglutide is superior, but dulaglutide is likely the preferred GLP1RA for most patients as it is associated with less adverse effects and unlike liraglutide it is a weekly injection and has been shown to be effective in primary prevention of CV events in high-risk patients. Liraglutide (Victoza) is a useful alternative for those who cannot tolerate dulaglutide 1.5 mg weekly, prefer daily weight manag..." current